你好,请登录   免费注册    |    收藏本站
联系电话: 0574-87917803
联系电话: call_new 0574-87917803
NCI-H865 [H865]
NCI-H865 [H865]
规格:
货期:
编号:TS211245
品牌:Testobio
产品名称: NCI-H865 H865
商品货号: TS211245
Organism: Homo sapiens, human
Tissue: lung
Product Format: frozen
Culture Properties: suspension, Cultures grow as floating aggregates of round cell clusters.
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: stage L,carcinoma; classic small cell lung cancer
Age: 54 years
Gender: female
Ethnicity: Caucasian
Applications:
The line was established in November 1984.
Derivation:
The line was established in November 1984.
Clinical Data:
The patient received prior chemotherapy and radiation therapy.
The patient was a smoker.
female
Caucasian
54 years
Comments:
The line was established in November 1984.
The patient received prior chemotherapy and radiation therapy.
The patient was a smoker.
40.
Complete Growth Medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
Subculturing:
Medium Renewal: Add fresh medium every 3 to 4 days (depending on cell density)
Cultures can be maintained by addition of fresh medium.
Cryopreservation:
Culture medium, 95%; DMSO, 5%
Culture Conditions:
Temperature: 37.0°C
STR Profile:
Amelogenin: X
CSF1PO: 14
D13S317: 8
D16S539: 9
D5S818: 12
D7S820: 10
THO1: 9.3
TPOX: 8
vWA: 17
Name of Depositor: AF Gazdar, JD Minna
Deposited As: Homo sapiens
Year of Origin: 1984
References:

NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.

首页 > 产品中心 > 微生物培养 > 菌株 > null > NCI-H865 [H865]

NCI-H865 [H865]

  • 货号: TS211245
  • 好评
询价
  • 品牌 : TESTOBIO
产品名称: NCI-H865 H865
商品货号: TS211245
Organism: Homo sapiens, human
Tissue: lung
Product Format: frozen
Culture Properties: suspension, Cultures grow as floating aggregates of round cell clusters.
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: stage L,carcinoma; classic small cell lung cancer
Age: 54 years
Gender: female
Ethnicity: Caucasian
Applications:
The line was established in November 1984.
Derivation:
The line was established in November 1984.
Clinical Data:
The patient received prior chemotherapy and radiation therapy.
The patient was a smoker.
female
Caucasian
54 years
Comments:
The line was established in November 1984.
The patient received prior chemotherapy and radiation therapy.
The patient was a smoker.
40.
Complete Growth Medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
Subculturing:
Medium Renewal: Add fresh medium every 3 to 4 days (depending on cell density)
Cultures can be maintained by addition of fresh medium.
Cryopreservation:
Culture medium, 95%; DMSO, 5%
Culture Conditions:
Temperature: 37.0°C
STR Profile:
Amelogenin: X
CSF1PO: 14
D13S317: 8
D16S539: 9
D5S818: 12
D7S820: 10
THO1: 9.3
TPOX: 8
vWA: 17
Name of Depositor: AF Gazdar, JD Minna
Deposited As: Homo sapiens
Year of Origin: 1984
References:

NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.

合作单位: